Advertisement
UK markets close in 5 hours 33 minutes
  • FTSE 100

    8,083.47
    +38.66 (+0.48%)
     
  • FTSE 250

    19,798.69
    -1.03 (-0.01%)
     
  • AIM

    754.69
    -0.18 (-0.02%)
     
  • GBP/EUR

    1.1630
    +0.0002 (+0.02%)
     
  • GBP/USD

    1.2430
    -0.0023 (-0.18%)
     
  • Bitcoin GBP

    53,385.62
    +213.72 (+0.40%)
     
  • CMC Crypto 200

    1,432.35
    +8.25 (+0.58%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • CRUDE OIL

    82.98
    -0.38 (-0.46%)
     
  • GOLD FUTURES

    2,328.80
    -13.30 (-0.57%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     
  • DAX

    18,193.99
    +56.34 (+0.31%)
     
  • CAC 40

    8,128.46
    +22.68 (+0.28%)
     

Company News For Jun 20, 2018

Ross Stores (ROST) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
  • AT&T Inc.’s T shares increased 0.6% after the company announced that there will be fewer commercials, personalized programming and smaller channel bundles following its acquisition of Time Warner

  • Shares of Foundation Medicine, Inc. FMI surged 28.5% on news that Swiss drug behemoth Roche was buying out the company for $2.4 billion

  • Cotiviti Holdings, Inc.’s COTV shares increased 10.3% after Verscend Technologies Inc agreed to buy the company for $4.9 billion

  • Shares of Sarepta Therapeutics, Inc. SRPT rose 36.8% after the company announced positive results from Phase 1/2 test on its microdystrophin gene therapy for Duchenne muscular dystrophy, or DMD


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Foundation Medicine, Inc. (FMI) : Free Stock Analysis Report
 
AT&T Inc. (T) : Free Stock Analysis Report
 
Sarepta Therapeutics, Inc. (SRPT) : Free Stock Analysis Report
 
Cotiviti Holdings, Inc. (COTV) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research